Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more
Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collaboration leveraging... Read more
Singapore: AstraZeneca has formed collaboration with Korea's LegoChem Biosciences to develop a novel antibiotic to treat drug-resistant... Read more
Singapore: Professor Ian Frazer and his team at the University of Queensland, have been awarded grant from Australia's National Health and... Read more
Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registration study SECURE.... Read more
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its US phase IIa pilot... Read more
Singapore: GE Healthcare Life Sciences has licensed Cellular Dynamics International, US-based commercial producer of human induced pluripotent... Read more
Singapore: AstraZeneca has signed a research collaboration with Fudan University, one of China's leading academic institutions in the area... Read more
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma... Read more
Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement to establish a Therapeutic... Read more
Survey Box